AHJIKAN's latest shareholder vote settled two concrete capital-allocation decisions. The company said resolutions approved at its June 26 annual general meeting included a year-end dividend of ¥52 a share, or ¥389.2mn in total, effective June 29. The same agenda also transferred ¥800mn from retained earnings into a reserve account.
| Item | Approved detail |
|---|---|
| Year-end dividend | ¥52 per share, total ¥389.2mn, effective June 29, 2026 |
| Reserve transfer | ¥800mn moved from retained earnings to a reserve account |
| Directors | Keiichi Ashikaga, Naozumi Ashikaga, Koji Fukushima, Mototake Yoshino |
| Audit & Supervisory Committee directors | Tomomi Takeda, Hideo Yamamoto, Rumiko Kumano |
That makes the reserve line the bigger number in the filing, and the more revealing one. Shareholders signed off on a cash return, but they also approved setting aside a larger amount within equity. For readers outside Japan, the practical takeaway is straightforward: this document confirms the balance the company chose between distribution and retention, not just the mechanics of the meeting.
The governance side was equally clear-cut. Shareholders approved four directors, excluding directors who serve on the Audit & Supervisory Committee: Keiichi Ashikaga, Naozumi Ashikaga, Koji Fukushima and Mototake Yoshino. They also approved three directors serving on the Audit & Supervisory Committee: Tomomi Takeda, Hideo Yamamoto and Rumiko Kumano. Naozumi Ashikaga, listed on the cover page as representative director and president, is among the elected directors.
What this report does not say is also worth noting. The filing gives no management explanation for the ¥800mn reserve transfer, no fresh operating update and no earnings outlook. It confirms that the resolutions passed and that the dividend terms are now effective, but it does not explain why management preferred this exact mix of payout and retained capital, or whether any of the director appointments represent a change in board composition rather than a renewal.
So the message here is narrow, but useful. AHJIKAN has formal shareholder approval for a modest year-end cash payout, a larger reserve allocation and its current seven-person director slate across the two board categories. That is a real business signal on capital treatment and governance, even if it leaves the broader strategy chapter for another day.